You are here

Industry News

Advamed Smart Brief

November 16, 2018
A measure that would repeal the medical device tax could garner over 60 votes in the Senate during the lame-duck session, Adv -More
November 16, 2018
Boston Scientific is planning a restructuring program from 2019 to 2021 and to cut operating annual expenses by up to $150 mi -More
November 16, 2018
A round of financing has brought in $29 million for RenalytixAI, a UK-based company that makes artificial intelligence-enable -More
November 16, 2018
The European Investment Bank has provided the final $4.52 million tranche of a three-year project, valued at approximately $1 -More
November 16, 2018
A preliminary prospectus has been filed by Valeritas for a public offering of around 44.1 million shares of common stock and  -More
November 16, 2018
A public offering of approximately 2.1 million Class A common shares has been priced by Helius Medical Technologies at $8.25  -More
November 16, 2018
Aetna has issued a positive coverage policy for Pulmonx's Zephyr endobronchial valve system, naming it as an approved broncho -More
November 16, 2018
NuVasive has launched the Brigade Lateral implant for lateral anterior lumbar interbody fusion spine surgery.  -More
November 16, 2018
The FDA has granted Abbott clearance to market its DRG Invisible Trial System, which is designed to provide trial treatment w -More
November 16, 2018
The FDA has given Terumo Cardiovascular Group 510(k) clearance for its CDI Blood Parameter Monitoring System 550, a next-gene -More

Industry News

RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...